6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one

Catalog No.: 
ACNWBU182
CAS No.: 
122001-78-9
Molecular Formula: 
C7H8N2O
Molecular Weight: 
136.15
6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$119.00In stockIn stock
10g98%$205.00In stockIn stock
25g98%$450.00In stockIn stock
100g98%$1746.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one
IUPAC Name2,5,6,7-tetrahydro-3H-cyclopenta[c]pyridazin-3-one
MDL No.MFCD07757617
Molecular FormulaC7H8N2O
Molecular Weight136.15
SMILESO=C1C=C(CCC2)C2=NN1
InChI KeyHZLVYABRXDPPSA-UHFFFAOYSA-N
Synonym2,5,6,7-tetrahydro-3H-cyclopenta[c]pyridazin-3-one(SALTDATA: FREE);2,5,6,7-Tetrahydro-cyclopenta[c]pyridazin-3-one;6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one;2H,3H,5H,6H,7H-Cyclopenta[c]pyridazin-3-one;3H-Cyclopenta[c]pyridazin-3-one, 2,5,6,7-tetrahydro-
CAS No.122001-78-9
PubChem CID5200288

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACNWBU182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNWBU182 route product structure diagram
    ACNWBU182122001-78-9In Stock
Inquiry

2. ACNWBU182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNWBU182 route product structure diagram
    ACNWBU182122001-78-9In Stock
Inquiry

3. ACNWBU182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNWBU182 route product structure diagram
    ACNWBU182122001-78-9In Stock
Inquiry

Comments (0)